Xeris Pharmaceuticals | XERS - Операционный доход





Операционный доход Изменить Дата
Celltrion KRW 12.9B 822.77M 2026-03
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -46.53M 23.01M 2026-03
Divis Laboratories Ltd INR 11.29B 3.15B 2026-06
Eli Lilly USD 12.46B 2.68B 2026-06
Kangmei Pharma CNY -35.26M 24.32M 2026-06
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 400K 2024-12
Medical Developments International AUD -36K 444K 2025-12
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Organigram Holdings CAD -9.79M 10.33M 2026-03
Ovoca Bio EUR -173K 990K 2025-12
Pacira USD 9.96M 5.33M 2026-06
Perrigo USD 23.5M 10.1M 2026-06
Pharma Mar EUR -1.4M 2.03M 2026-06
Qiagen NV USD 141.4M 24.77M 2026-06
Sartorius EUR 164M 3.3M 2026-06
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Supernus Pharmaceuticals USD -21.04M 14.21M 2026-06
Tilray USD -20.01M 9.34M 2025-09
Zealand Pharma A/S -539M 168.05M 2026-03
Zz Pientze Pharmaceu CNY 362.83M 474.98M 2026-06